Senior insider sale
Chief Financial Officer at LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$2.74M
13.42K shares
What this filing means
ESPINOZA OCTAVIO plans to sell 13.42K shares of LIGAND PHARMACEUTICALS INC valued at approximately $2.74M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/4/2026ACC: 0001950047-26-002183
Officer· Chief Financial Officer
Since Mar 2026
13.42K
Shares to sell
$2.74M
Approx. market value
13.42K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
3/4/2026
2.07KRestricted & Performance Stock Units
N/A
12/31/2025
11.35KTotal acquired13.42K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2026 | Exercise of Stock Options Cash | 2.07K | — |
12/31/2025 | Restricted & Performance Stock Units N/A | 11.35K | — |
| Total | 13.42K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
13.42K
Market value
$2.74M
3/4/2026
Total
Units
13.42K
Value
$2.74M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/4/2026 | 13.42K | $2.74M | NASDAQ | Planned |
| Total | 13.42K | $2.74M | ||